Armored CAR T cells show early signs of clinical activity in patients with castration-resistant prostate cancer, paving the way for further development and optimization.
Your institute does not have access to this article
Subscription info for Chinese customers
We have a dedicated website for our Chinese customers. Please go to naturechina.com to subscribe to this journal.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Narayan, V. et al. Nat. Med. https://doi.org/10.1038/s41591-022-01726-1 (2022).
Rosa, K. OncLive https://www.onclive.com/view/p-psma-101-elicits-encouraging-responses-in-metastatic-castration-resistant-prostate-cancer (September 2021).
Neelapu, S. S. Blood 133, 1799–1800 (2019).
Fabrizio, V. A. et al. Blood Adv. https://doi.org/10.1182/BLOODADVANCES.2021006418 (2021).
Dorff, T. B. et al. Clin. Cancer Res. 28, 576–584 (2022).
Stultz, J. & Fong, L. Prostate Cancer Prostatic Dis. 24, 697 (2021).
Biasco, L. et al. Nat. Cancer 2, 629–642 (2021).
US Food and Drug Administration. https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/kymriah-tisagenlecleucel (accessed February 2022).
US Food and Drug Administration. https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/yescarta-axicabtagene-ciloleucel (accessed February 2022).
Rafiq, S., Hackett, C. S. & Brentjens, R. J. Nat. Rev. Clin. Oncol. 17, 147–167 (2019).
Netto, G. J. & Epstein, J. I. in Diagnostic Immunohistochemistry 3rd edn. (ed. Dabbs, D. J.) 593–661 (Elsevier, 2011).
Fan, A. C. & Leppert, J. T. JAMA Netw. Open 2, e199233 (2019).
N.P.T., S.M.N. and J.L.G. are employees of the National Cancer Institute, US National Institutes of Health.
About this article
Cite this article
Tschernia, N.P., Norberg, S.M. & Gulley, J.L. CAR T cells reach clinical milestone in prostate cancer. Nat Med 28, 635–636 (2022). https://doi.org/10.1038/s41591-022-01742-1